Submission of Research for Review
All study-related submissions (including requests to amend approved protocols) must be signed by the study's principal investigator and sent in hard copy by regular mail or hand delivered to the IRB office. The only exception to this rule is the electronic submission of the continuing review application via PRISM.
All other Correspondence
We welcome your questions, and we ask that your use our email address for all other communication. Please include the PI-IRB protocol number in the subject line of all correspondence.
Please note: IRB administrators read and "triage" IRBmail daily, have ready access to protocol files, and assign each query for response. Please DO NOT email Administrators or the Chair directly on protocol matters as this risks loss or delay in responding to your request. It is also not necessary to cc any of us individually on queries addressed to IRBMail. Urgent patient care related queries will be forwarded immediately to the Chairman from IRBMail.
|
Address
|
1051 Riverside Drive, Box 10, New York, NY 10032
|
|
Location
|
Suite 5200, New PI Building
|
|
Phone
|
212-543-2062
|
|
Fax
|
212-543-5757
|
|
Email
|
IRBMail@pi.cpmc.columbia.edu
|